Pages that link to "Q34313195"
Jump to navigation
Jump to search
The following pages link to Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors (Q34313195):
Displaying 50 items.
- TRIM39 is a MOAP-1-binding protein that stabilizes MOAP-1 through inhibition of its poly-ubiquitination process (Q24309591) (← links)
- Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2 (Q28209990) (← links)
- Proteasome inhibitor PS-341 induces apoptosis in cisplatin-resistant squamous cell carcinoma cells by induction of Noxa (Q28259620) (← links)
- HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma (Q28468451) (← links)
- Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer (Q28975773) (← links)
- Bortezomib-based chemotherapy regimens can improve response in newly diagnosed multiple myeloma patients with bcl-2 and survivin overexpression (Q34029221) (← links)
- Targeting SQSTM1/p62 induces cargo loading failure and converts autophagy to apoptosis via NBK/Bik (Q34056627) (← links)
- Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors (Q34073160) (← links)
- BAX/BAK-independent mitoptosis during cell death induced by proteasome inhibition? (Q34082489) (← links)
- BH3-only proteins in apoptosis and beyond: an overview (Q34085370) (← links)
- BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes (Q34085382) (← links)
- Inhibiting NF-κB activation by small molecules as a therapeutic strategy (Q34205025) (← links)
- The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors (Q34218976) (← links)
- Antitumor activity and downregulation of pro-angiogenic molecules in human prostate cancer cells by a novel thiazolidione compound (Q34314188) (← links)
- Distinct molecular mechanisms responsible for bortezomib-induced death of therapy-resistant versus -sensitive B-NHL cells (Q34541718) (← links)
- IFN-alpha and bortezomib overcome Bcl-2 and Mcl-1 overexpression in melanoma cells by stimulating the extrinsic pathway of apoptosis (Q34598755) (← links)
- Proteasome inhibition by bortezomib decreases proliferation and increases apoptosis in ovarian granulosa cell tumors. (Q34602025) (← links)
- Oppositional regulation of Noxa by JNK1 and JNK2 during apoptosis induced by proteasomal inhibitors (Q34674973) (← links)
- Activation of sterile20-like kinase 1 in proteasome inhibitor bortezomib-induced apoptosis in oncogenic K-ras-transformed cells (Q34696370) (← links)
- Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation (Q35070129) (← links)
- Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus (Q35100683) (← links)
- Proteasome inhibition enhances the killing effect of BikDD gene therapy (Q35440131) (← links)
- MicroRNA library screening identifies growth-suppressive microRNAs that regulate genes involved in cell cycle progression and apoptosis. (Q35814865) (← links)
- Bortezomib inhibits cell proliferation in prostate cancer (Q35943077) (← links)
- Formation of Tankyrase Inhibitor-Induced Degradasomes Requires Proteasome Activity (Q36092368) (← links)
- Proteasome inhibition as novel treatment strategy in leukaemia (Q36513273) (← links)
- Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapy (Q36526514) (← links)
- BCL-2 family regulation by the 20S proteasome inhibitor bortezomib (Q36935301) (← links)
- Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway (Q37160844) (← links)
- Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis. (Q37713998) (← links)
- Targeting NF-kappaB for colorectal cancer (Q37724387) (← links)
- Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress (Q38343228) (← links)
- Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism (Q38353509) (← links)
- Cell Death Signaling (Q38655649) (← links)
- Breast cancer cell line MDA-MB-231 miRNA profile expression after BIK interference: BIK involvement in autophagy. (Q38812088) (← links)
- The increase in BIK expression following ERK1/2 pathway inhibition is a consequence of G₁ cell-cycle arrest and not a direct effect on BIK protein stability (Q39023942) (← links)
- Anticancer activity of an antisense oligonucleotide targeting TRADD combined with proteasome inhibitors in chemoresistant hepatocellular carcinoma cells. (Q39091457) (← links)
- Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells (Q39310876) (← links)
- The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells (Q39362752) (← links)
- Src tyrosine kinase inhibits apoptosis through the Erk1/2- dependent degradation of the death accelerator Bik. (Q39386079) (← links)
- Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implications (Q39404414) (← links)
- The anti-apoptotic protein BCL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression. (Q39755661) (← links)
- Bmf is upregulated by PS-341-mediated cell death of glioma cells through JNK phosphorylation (Q39876126) (← links)
- Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors. (Q39926659) (← links)
- Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells (Q39970394) (← links)
- Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathways (Q39993811) (← links)
- Evidence for involvement of BH3-only proapoptotic members in adenovirus-induced apoptosis (Q40102733) (← links)
- Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia (Q40131183) (← links)
- Proteasome inhibitors induce death but activate NF-kappaB on endometrial carcinoma cell lines and primary culture explants (Q40273672) (← links)
- Elevated calpain activity in acute myelogenous leukemia correlates with decreased calpastatin expression (Q40787136) (← links)